Outsourced Pharma

Outsourced Pharma
Share

Outsourced Pharma

 •  January 16

East Rutherford, NJ (GLOBE NEWSWIRE) - Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently held an opening ceremony with AstraZeneca, at its Karlskoga, Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies for a key...

Outsourced Pharma

 •  November 14, 2017

Quotient Sciences (“Quotient”), the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K. The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the U.K., and further supports the growth of...

Outsourced Pharma

 •  November 14, 2017

Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs ADC Biotechnology (ADC Bio)‘s leading experts warn that best in class ADCs are being overlooked due to critical aggregation control problems. CDMOs are unable to develop products which are capable of working successfully in clinical testing...

Outsourced Pharma

 •  November 8, 2017

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant. The project has seen the installation of two 500 gallon glass lined reactors and creates a third small...

Outsourced Pharma

 •  October 30, 2017

Leading outsourcing provider PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at its center of excellence for contained manufacturing, Tredegar, UK. This investment delivers another important capability for the award-winning facility in the development and manufacturing of...

Outsourced Pharma

 •  October 27, 2017

Sharp, a global provider of pharmaceutical packaging and clinical services and part of UDG Healthcare, has reached a milestone in its track and trace programme by equipping its 50th line with serialisation capabilities ahead of the U.S. and European regulatory deadlines in 2018/19 aimed at preventing counterfeit product from entering the supply...

Outsourced Pharma

 •  October 24, 2017

Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced it has completed the acquisition of Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services. The acquisition of this...

Outsourced Pharma

 •  October 24, 2017

Country accounts for over 20% of global production with $20B exports forecast by 2020 The India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) provide an update on the country’s generics market as the world’s pharma industry meets for its annual exposition at CPhI Worldview in Frankfurt. Data confirms...

Outsourced Pharma

 •  October 23, 2017

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently announced the completion of an expansion to its large scale production capacity at its Charles City, Iowa plant. The investment included the installation of 1,000 and 4,000 gallon glass lined reactors in addition...

Outsourced Pharma

 •  October 19, 2017

TraceLink, Sharp and Major Pharma Brand to Discuss Trade Partner Connectivity at CPhI Worldwide
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, recently announced that more than 100 contract manufacturing organizations...